| Patient | Josephine Baker |
|---|---|
| Date of birth | 1963-06-03 |
| Identifiers | MRN HR-ML049-SYN; SSN (made up) 000-49-3172 |
| Document date | 2026-09-15 |
| Author | Colette Ashby-Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Ms. Baker returns for a preventive visit, eight weeks after her twelve-week review. She finished cardiac rehabilitation in the summer and has been rehearsing four mornings a week without chest pain or breathlessness; she plans to sing and dance in a short run of concerts this autumn. The nosebleed in June has not come back. She has not had a mammogram or a colon test for many years and asks what she is due for. She takes all her medicines from a weekly pill box. Her finances remain strained but she has a contract for the autumn concerts. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit |
| Since the last visit | Cardiac rehabilitation completed; rehearsing four mornings a week; no angina or bleeding |
| Medicines | Aspirin, clopidogrel, atorvastatin, metoprolol, lisinopril and nitroglycerin as needed (not used) |
| Active conditions | Coronary artery disease after a stent; high blood pressure, controlled |
Health risk assessment. Self-completed on paper before the visit and reviewed with her by Dr. Ashby-Nwosu. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the spring |
| Psychosocial | Worries about money and her children; enjoys rehearsing again; supportive friends; PHQ-2 score 0 |
| Behavioral | Never smoker; alcohol rarely (AUDIT-C 1); exercises most days; sleeps about seven hours |
| Nutrition | Regular meals since rehabilitation, more vegetables and fish; little salt |
| Safety | Wears a seat belt; smoke detector working; no firearms at home |
| Activities of daily living | Independent in all activities and instrumental activities |
| Hearing and vision | Hears well; reading glasses; no eye examination in several years |
| Sexual health | Not sexually active at present; no concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No further nosebleeds; no hearing loss |
| Cardiovascular | Negative | No chest pain, palpitations, orthopnea or ankle swelling |
| Respiratory | Negative | No breathlessness on rehearsing or on stairs |
| Gastrointestinal | Negative | Regular bowel habit; no bleeding or black stools |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | Stiff knees after long rehearsals; no muscle aches on atorvastatin |
| Integumentary | Negative | No new or changing skin lesions; no unusual bruising |
| Neurological | Negative | No headache, weakness, numbness or speech change |
| Psychiatric | Negative | Mood good; sleeping better |
| Breast | Negative | No lumps, pain or nipple discharge |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-24 | active | S |
| Ticagrelor 90 mg oral tablet, one tablet twice daily | One tablet twice daily | Oral route | 2026-03-24 to 2026-04-28 | completed | S |
| Clopidogrel 75 mg oral tablet: a 600 mg loading dose (eight tablets) 24 hours after the last ticagrelor, then one tablet daily | One tablet daily after a 600 mg loading dose | Oral route | 2026-04-28 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-24 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-24 | active | S |
| Lisinopril 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-24 to 2026-04-28 | completed | S |
| Lisinopril 10 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-04-28 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if the pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 2026-03-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-15 | Body height | 168 | cm | S |
| 2026-09-15 | Body weight | 60.6 | kg | S |
| 2026-09-15 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 2026-09-15 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-09-15 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-09-15 | Heart rate | 58 | /min | S |
| 2026-09-15 | Respiratory rate | 14 | /min | S |
| 2026-09-15 | Body temperature | 36.6 | Cel | S |
| 2026-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-15 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-09-15 | Total score [AUDIT-C] | 1 | {score} | S |
Vital signs recorded on 2026-09-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well and energetic; blood pressure 124/76, pulse 58; BMI 21.5 |
| Eyes | Pupils equal and reactive; fundi normal |
| Ears, nose and throat | Nasal mucosa healed; tympanic membranes normal |
| Neck | No thyroid enlargement; no carotid bruits |
| Cardiovascular | Regular rhythm; no murmur; radial pulse normal; no edema |
| Respiratory | Clear |
| Breast | No masses, skin change or axillary nodes, examined with a chaperone present |
| Abdomen | Soft and non-tender; well-healed lower midline scar |
| Musculoskeletal | Full range of motion; mild crepitus in both knees |
| Skin | No suspicious lesions |
| Psychiatric | Bright and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) | resolved | confirmed | R06.09 | S — Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology attributed it to ticagrelor. |
| Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1969 | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the 1969 heart attack remains D in the history. |
| High blood pressure, found during the hospital stay for the heart attack | active | confirmed | I10 | S — Synthetic modern diagnosis; no claim about her real blood pressure. |
| Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | active | provisional | Z90.710 | S — Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source. |
| Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel | resolved | confirmed | T45.525A | S — Synthetic diagnosis at the second visit; resolved at the third visit after the switch. |
| Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor | active | confirmed | E78.41 | S — Synthetic result measured once at the second visit. |
| Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers | active | confirmed | Z59.86 | S — Synthetic social need anchored to her documented debts and the loss of Les Milandes. |
| Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleeding | resolved | confirmed | R04.0 | S — Synthetic intercurrent problem at an unscheduled visit; it follows from dual antiplatelet therapy and does not echo a documented illness. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 124/76 mmHg, at goal |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 1 |
| Tobacco use | Not indicated | Never smoker |
| Influenza vaccine | Completed today | This season's vaccine given today |
| COVID-19 vaccine | Completed today | This season's vaccine given today after discussion |
| Pneumococcal vaccine | Completed today | PCV20 given today; no further doses needed |
| RSV vaccine | Due | Advised for adults 50 to 74 with heart disease; planned at the seven-month review so that today's vaccines are not too many at once |
| Recombinant zoster vaccine | Due | Never given; first dose at the seven-month review |
| Tetanus booster | Due | No record within ten years; Tdap at the seven-month review |
| Breast cancer screening (mammogram) | Ordered | Every two years from 40 to 74; none in many years |
| Colorectal cancer screening | Ordered | Age 45 to 75; never screened. A stool immunochemical (FIT) kit today, because a colonoscopy within the first year after a stent would mean stopping clopidogrel |
| Cervical cancer screening | Not indicated | Hysterectomy with removal of the cervix for a reason other than cancer or precancer |
| Bone density (DXA) | Ordered | Under 65, but at increased risk from a possible early menopause after hysterectomy in her thirties |
| Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested |
| HIV screening | Ordered | One-time screening for adults 15 to 65; never tested; she agreed |
| Hormone therapy for prevention | Not indicated | Not recommended to prevent chronic conditions after menopause |
| Lipids and diabetes screening | Up to date | LDL 62 mg/dL in July on atorvastatin; hemoglobin A1c 5.6% in April |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never smoker; aneurysm screening applies to men who have smoked |
| Eye examination | Referred | Optometry for a routine eye examination; none in several years |
Immunizations given today: Influenza vaccine, this season; COVID-19 vaccine, mRNA, this season; Pneumococcal conjugate vaccine PCV20, single dose [S]
Guideline basis: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Breast Cancer: Screening (2024); Colorectal Cancer: Screening (2021); Cervical Cancer: Screening (2018); Osteoporosis to Prevent Fractures: Screening (2025); Hepatitis C Virus Infection in Adolescents and Adults: Screening (2020); Human Immunodeficiency Virus (HIV) Infection: Screening (2019); Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions (2022); Adult Immunization Schedule by Age (2026)
Follow-up: Mammogram and DXA booked; FIT kit to return by mail; hepatitis C and HIV tests drawn today; optometry. Seven-month review in five weeks with RSV, zoster and Tdap vaccines. Next preventive visit in one year. Next scheduled visit 2026-10-20: seven-month review: antiplatelet plan to twelve months, blood pressure, kidney function, angina status and plans for the year. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. After the heart attack she wanted her wishes written down. She named a longtime friend as her health care agent, and the form was completed and copied into the chart. She wants full treatment, including resuscitation, for any illness she might recover from, and she wants her children cared for if she is ill. If she had a severe stroke or other illness with little chance of recovering her ability to speak, move and recognize the people she loves, she would not want long-term life support and would want to be kept comfortable. She will tell her agent and her family. [S]